| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/26/2023 | ACACIA RESEARCH CORP | ACTG | Grant | ACTG Common Stock | 30.5k | $0.00 | $0 | | 05/26/2023 |
| 05/09/2022 | ACACIA RESEARCH CORP | ACTG | Grant | ACTG Common Stock | 26.2k | $0.00 | $0 | | 05/09/2022 |
| 05/10/2021 | ACACIA RESEARCH CORP | ACTG | Grant | ACTG Common Stock | 21.7k | $0.00 | $0 | | 05/10/2021 |
| 09/08/2020 | ACACIA RESEARCH CORP | ACTG | Purchase | ACTG Common Stock | 13.5k | $3.77 | $50.8k | | 09/04/2020 |
| 09/04/2020 | ACACIA RESEARCH CORP | ACTG | Purchase | ACTG Common Stock | 11.5k | $3.78 | $43.6k | | 09/04/2020 |
| 07/22/2020 | HARTE HANKS INC | HRTH | Exercise | Restricted Stock Units | 4.6k | $0.00 | $0 | | 03/21/2020 |
| 06/02/2020 | ACACIA RESEARCH CORP | ACTG | Grant | ACTG Common Stock | 48k | $0.00 | $0 | | 06/02/2020 |
| 03/21/2020 | HARTE HANKS INC | HRTH | Exercise | Restricted Stock Units | 23.1k | $0.00 | $0 | | 03/21/2020 |
| 05/08/2019 | ACACIA RESEARCH CORP | ACTG | Grant | ACTG Common Stock | 22.4k | $0.00 | $0 | | 05/08/2019 |
| 03/21/2019 | HARTE HANKS INC | HRTH | Grant | | 23.1k | $0.00 | $0 | | 03/21/2019 |
| 07/27/2018 | HARTE HANKS INC | HRTH | Grant | Common Stock | 6.8k | $0.00 | $0 | | 07/27/2018 |
| 02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Common Stock, Class A | 5.1k | $18.00 | $92.3k | | 02/13/2018 |
| 02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Director Stock Option (right to buy) | 30k | $5.19 | $155.7k | | 02/13/2018 |
| 02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Director Stock Option (right to buy) | 20k | $8.62 | $172.4k | | 02/13/2018 |
| 02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Director Stock Option (right to buy) | 20k | $6.80 | $136k | | 02/13/2018 |
| 02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Director Stock Option (right to buy) | 20k | $16.23 | $324.6k | | 02/13/2018 |
| 02/13/2018 | Sucampo Pharmaceuticals, Inc. | SCMP | Disposition | Director Stock Option (right to buy) | 10k | $10.30 | $103k | | 02/13/2018 |
| 09/18/2017 | SCHOLASTIC CORP | SCHL | Payment of Exercise | Common Stock | 898 | $39.04 | $35.1k | | 09/18/2017 |
| 06/01/2017 | Sucampo Pharmaceuticals, Inc. | SCMP | Grant | | 5.1k | $0.00 | $0 | | 06/01/2017 |
| 06/01/2017 | Sucampo Pharmaceuticals, Inc. | SCMP | Grant | Director Stock Option (right to buy) | 10k | $10.30 | $103k | | 06/01/2017 |
| 01/04/2017 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 8.3k | $47.45 | $392.1k | | 01/04/2017 |
| 12/20/2016 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 9.6k | $48.08 | $461.4k | | 12/20/2016 |
| 12/20/2016 | SCHOLASTIC CORP | SCHL | Exercise | Employee stock option (right to buy) | 9.6k | $33.87 | $325.1k | | 12/20/2016 |
| 12/20/2016 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 4.5k | $48.32 | $218.5k | | 12/19/2016 |
| 12/19/2016 | SCHOLASTIC CORP | SCHL | Exercise | Employee Stock Option (right to buy) | 11.6k | $30.17 | $351.3k | | 12/19/2016 |
| 12/19/2016 | SCHOLASTIC CORP | SCHL | Exercise | Employee stock option (right to buy) | 11.6k | $33.87 | $392.8k | | 12/19/2016 |
| 12/19/2016 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 11.6k | $48.02 | $559.2k | | 12/19/2016 |
| 12/19/2016 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 11.6k | $48.01 | $556.8k | | 12/19/2016 |
| 12/19/2016 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 5.5k | $47.97 | $262.8k | | 12/19/2016 |
| 12/19/2016 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 25 | $48.00 | $1.2k | By son, as custodian | 12/19/2016 |
| 10/09/2012 | SCHOLASTIC CORP | SCHL | Payment of Exercise | Common Stock | 1.6k | $33.64 | $52.7k | | 10/09/2012 |
| 10/03/2012 | SCHOLASTIC CORP | SCHL | Exercise | Employee Stock Options (right to buy) | 5.4k | $27.93 | $150k | | 10/02/2012 |
| 10/03/2012 | SCHOLASTIC CORP | SCHL | Exercise | Employee Stock Option (right to buy) | 6k | $22.81 | $136.9k | | 10/02/2012 |
| 10/03/2012 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 5.4k | $32.70 | $175.6k | | 10/02/2012 |
| 10/03/2012 | SCHOLASTIC CORP | SCHL | Sale | Common Stock | 6k | $32.70 | $196.2k | | 10/02/2012 |
|